STRATA Skin Sciences (SSKN) Net Income Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.87% |
| Sep 30, 2025 | -5.28% |
| Jun 30, 2025 | -8.92% |
| Mar 31, 2025 | -15.44% |
| Dec 31, 2024 | -49.82% |
| Sep 30, 2024 | -19.25% |
| Jun 30, 2024 | 2.47% |
| Mar 31, 2024 | -20.35% |
| Dec 31, 2023 | -73.31% |
| Sep 30, 2023 | -11.61% |
| Jun 30, 2023 | -6.57% |
| Mar 31, 2023 | -6.38% |
| Dec 31, 2022 | 33.49% |
| Sep 30, 2022 | 44.61% |
| Jun 30, 2022 | -22.60% |
| Mar 31, 2022 | 8.84% |
| Dec 31, 2021 | 0.87% |
| Sep 30, 2021 | 19.16% |
| Jun 30, 2021 | 16.79% |
| Mar 31, 2021 | 6.71% |
| Dec 31, 2020 | 31.68% |
| Sep 30, 2020 | 30.80% |
| Jun 30, 2020 | 29.78% |
| Mar 31, 2020 | 29.53% |
| Dec 31, 2019 | 35.18% |
| Sep 30, 2019 | 28.25% |
| Jun 30, 2019 | 23.97% |
| Mar 31, 2019 | 22.39% |
| Dec 31, 2018 | 15.60% |
| Sep 30, 2018 | 37.60% |
| Jun 30, 2018 | 25.96% |
| Mar 31, 2018 | 20.45% |
| Dec 31, 2017 | 31.43% |
| Sep 30, 2017 | -28.90% |
| Jun 30, 2017 | 19.61% |
| Mar 31, 2017 | 7.15% |
| Dec 31, 2016 | 27.82% |
| Sep 30, 2016 | 24.42% |
| Jun 30, 2016 | 16.03% |
| Mar 31, 2016 | 7.11% |
| Dec 31, 2015 | 11.83% |
| Sep 30, 2015 | -9.76% |
| Jun 30, 2015 | -16.44% |